Designing a next generation multi-epitope based peptide vaccine candidate against SARS-CoV-2 using computational...

Area of Science:

• Immunology
• Vaccinology
• Computational Biology

Background:

• The COVID-19 pandemic, caused by SARS-CoV-2, has led to significant global mortality and necessitated rapid development of preventive measures.
• The Spike (S) glycoprotein of SARS-CoV-2 is a key target for vaccine development due to its role in triggering host immune responses.

Purpose of the Study:

• To design a novel Multi-epitope-based Peptide (MEBP) vaccine candidate targeting the SARS-CoV-2 Spike protein.
• To computationally evaluate the immunogenic potency and efficacy of the designed MEBP vaccine construct.

Main Methods:

• Systematic computational protocol for predicting dual-purpose epitopes (eliciting both humoral and cellular immunity).
• Design and 3D structure validation of the MEBP vaccine construct.
• In silico interaction studies, cloning, and immune response simulation based on vaccine dosage.

Main Results:

• Identification of potent, dual-purpose epitopes screened against stringent criteria for maximum antigen coverage.
• In silico simulations demonstrated rapid antigen clearance via antibody generation and enhanced cell-mediated immunity upon repeated vaccine exposure.
• The MEBP vaccine construct showed strong immunogenic potential in computational evaluations.

Conclusions:

• The designed MEBP vaccine candidate is computationally validated as a potent option for COVID-19 prevention.
• The study indicates readiness for experimental validation and efficacy testing of this novel vaccine construct.